Page 333 - Drug Class Review
P. 333
Final Report Update 1 Drug Effectiveness Review Project
11. Is there important differential loss to follow-up or overall high loss to follow-up? (Give numbers in
each group.)
Assessment of External Validity (Generalizability)
1. How similar is the population to the population to whom the intervention would be applied?
2. How many patients were recruited?
3. What were the exclusion criteria for recruitment? (Give numbers excluded at each step.)
4. What was the funding source and role of funder in the study?
5. Did the control group receive the standard of care?
6. What was the length of follow-up? (Give numbers at each stage of attrition.)
Alzheimer's Drugs Page 200 of 205
